{"id":"https://openalex.org/W7204716844","doi":"https://doi.org/10.1016/s2152-2650(26)02194-4","title":"CML-1324: Ischemic Priapism as the Initial Manifestation of Chronic Myeloid Leukemia: Successful Transition to Asciminib After Dasatinib-Induced Severe Pulmonary Hypertension","display_name":"CML-1324: Ischemic Priapism as the Initial Manifestation of Chronic Myeloid Leukemia: Successful Transition to Asciminib After Dasatinib-Induced Severe Pulmonary Hypertension","publication_year":2026,"publication_date":"2026-08-01","ids":{"openalex":"https://openalex.org/W7204716844","doi":"https://doi.org/10.1016/s2152-2650(26)02194-4"},"language":"en","primary_location":{"id":"doi:10.1016/s2152-2650(26)02194-4","doi":"https://doi.org/10.1016/s2152-2650(26)02194-4","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(26)02194-4","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2669","issn":["2152-2669","2152-2650"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089259988","display_name":"Ahmed Embaby","orcid":"https://orcid.org/0000-0002-9078-0463","observed_orcids":["https://orcid.org/0000-0002-9078-0463"]},"institutions":[{"id":"https://openalex.org/I192398990","display_name":"Zagazig University","ror":"https://ror.org/053g6we49","country_code":"EG","type":"education","lineage":["https://openalex.org/I192398990"]},{"id":"https://openalex.org/I4210113049","display_name":"Armed Forces Hospital","ror":"https://ror.org/024eyyq66","country_code":"SA","type":"healthcare","lineage":["https://openalex.org/I4210113049"]}],"countries":["EG","SA"],"is_corresponding":false,"raw_author_name":"Ahmed Embaby","raw_affiliation_strings":["Adult Clinical Hematology Unit, Hematology and Oncology Department, Al Hada Armed Forces Hospital, Taif, Saudi Arabia","Clinical Hematology Unit, Internal Medicine Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adult Clinical Hematology Unit, Hematology and Oncology Department, Al Hada Armed Forces Hospital, Taif, Saudi Arabia","institution_ids":["https://openalex.org/I4210113049"]},{"raw_affiliation_string":"Clinical Hematology Unit, Internal Medicine Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt","institution_ids":["https://openalex.org/I192398990"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5117601433","display_name":"Ammar Babateen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113049","display_name":"Armed Forces Hospital","ror":"https://ror.org/024eyyq66","country_code":"SA","type":"healthcare","lineage":["https://openalex.org/I4210113049"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Ammar Babateen","raw_affiliation_strings":["Adult Clinical Hematology Unit, Hematology and Oncology Department, Al Hada Armed Forces Hospital, Taif, Saudi Arabia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adult Clinical Hematology Unit, Hematology and Oncology Department, Al Hada Armed Forces Hospital, Taif, Saudi Arabia","institution_ids":["https://openalex.org/I4210113049"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077633779","display_name":"Amro Ibrahim","orcid":"https://orcid.org/0000-0003-4612-8803","observed_orcids":["https://orcid.org/0000-0003-4612-8803"]},"institutions":[{"id":"https://openalex.org/I4210113049","display_name":"Armed Forces Hospital","ror":"https://ror.org/024eyyq66","country_code":"SA","type":"healthcare","lineage":["https://openalex.org/I4210113049"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Amro Ibrahim","raw_affiliation_strings":["Adult Clinical Hematology Unit, Hematology and Oncology Department, Al Hada Armed Forces Hospital, Taif, Saudi Arabia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adult Clinical Hematology Unit, Hematology and Oncology Department, Al Hada Armed Forces Hospital, Taif, Saudi Arabia","institution_ids":["https://openalex.org/I4210113049"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148710462","display_name":"Mazen Al Malki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113049","display_name":"Armed Forces Hospital","ror":"https://ror.org/024eyyq66","country_code":"SA","type":"healthcare","lineage":["https://openalex.org/I4210113049"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Mazen Al Malki","raw_affiliation_strings":["Adult Clinical Hematology Unit, Hematology and Oncology Department, Al Hada Armed Forces Hospital, Taif, Saudi Arabia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adult Clinical Hematology Unit, Hematology and Oncology Department, Al Hada Armed Forces Hospital, Taif, Saudi Arabia","institution_ids":["https://openalex.org/I4210113049"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5133224003","display_name":"Othman Ayoub","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113049","display_name":"Armed Forces Hospital","ror":"https://ror.org/024eyyq66","country_code":"SA","type":"healthcare","lineage":["https://openalex.org/I4210113049"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Othman Ayoub","raw_affiliation_strings":["Adult Clinical Hematology Unit, Hematology and Oncology Department, Al Hada Armed Forces Hospital, Taif, Saudi Arabia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adult Clinical Hematology Unit, Hematology and Oncology Department, Al Hada Armed Forces Hospital, Taif, Saudi Arabia","institution_ids":["https://openalex.org/I4210113049"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5060835146","display_name":"Muteb Althomali","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113049","display_name":"Armed Forces Hospital","ror":"https://ror.org/024eyyq66","country_code":"SA","type":"healthcare","lineage":["https://openalex.org/I4210113049"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Muteb Althomali","raw_affiliation_strings":["Adult Clinical Hematology Unit, Hematology and Oncology Department, Al Hada Armed Forces Hospital, Taif, Saudi Arabia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adult Clinical Hematology Unit, Hematology and Oncology Department, Al Hada Armed Forces Hospital, Taif, Saudi Arabia","institution_ids":["https://openalex.org/I4210113049"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3890,"currency":"USD","value_usd":3890},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"26","issue":null,"first_page":"S693","last_page":"S694"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ischemic-priapism","display_name":"ischemic priapism","score":0.8700000047683716},{"id":"https://openalex.org/keywords/asciminib","display_name":"asciminib","score":0.7860000133514404},{"id":"https://openalex.org/keywords/dasatinib","display_name":"dasatinib","score":0.9729999899864197},{"id":"https://openalex.org/keywords/pulmonary-hypertension","display_name":"pulmonary hypertension","score":0.9789999723434448},{"id":"https://openalex.org/keywords/bcr-abl1","display_name":"BCR-ABL1","score":0.6230000257492065},{"id":"https://openalex.org/keywords/hyperviscosity","display_name":"hyperviscosity","score":0.6779999732971191},{"id":"https://openalex.org/keywords/leukostasis","display_name":"leukostasis","score":0.8159999847412109},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.7179999947547913},{"id":"https://openalex.org/keywords/molecular-response","display_name":"molecular response","score":0.4830000102519989},{"id":"https://openalex.org/keywords/hydroxyurea","display_name":"hydroxyurea","score":0.6000000238418579},{"id":"https://openalex.org/keywords/splenomegaly","display_name":"splenomegaly","score":0.7360000014305115},{"id":"https://openalex.org/keywords/pleural-effusion","display_name":"pleural effusion","score":0.6880000233650208}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9907000064849854},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7059999704360962},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.6852999925613403},{"id":"https://openalex.org/C2780930700","wikidata":"https://www.wikidata.org/wiki/Q1128595","display_name":"Pulmonary hypertension","level":2,"score":0.6822999715805054},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.3935999870300293},{"id":"https://openalex.org/C81182388","wikidata":"https://www.wikidata.org/wiki/Q353963","display_name":"Complication","level":2,"score":0.2533000111579895},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.24220000207424164},{"id":"https://openalex.org/C2780940725","wikidata":"https://www.wikidata.org/wiki/Q206280","display_name":"Pulmonary artery","level":2,"score":0.2320999950170517},{"id":"https://openalex.org/C2780345856","wikidata":"https://www.wikidata.org/wiki/Q156590","display_name":"Priapism","level":2,"score":0.21940000355243683},{"id":"https://openalex.org/C194232998","wikidata":"https://www.wikidata.org/wiki/Q1606712","display_name":"Transition (genetics)","level":3,"score":0.21860000491142273}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s2152-2650(26)02194-4","doi":"https://doi.org/10.1016/s2152-2650(26)02194-4","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(26)02194-4","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2669","issn":["2152-2669","2152-2650"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2964976976","https://openalex.org/W7217537259","https://openalex.org/W4383823985","https://openalex.org/W2977854863","https://openalex.org/W4313132318","https://openalex.org/W3085686021","https://openalex.org/W2795675453","https://openalex.org/W2588217962","https://openalex.org/W2993650930","https://openalex.org/W3176013460"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-08-31T00:00:00"}